1509 related articles for article (PubMed ID: 11899259)
1. Beta-amyloid, neuronal death and Alzheimer's disease.
Carter J; Lippa CF
Curr Mol Med; 2001 Dec; 1(6):733-7. PubMed ID: 11899259
[TBL] [Abstract][Full Text] [Related]
2. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
4. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease.
Takahashi RH; Nagao T; Gouras GK
Pathol Int; 2017 Apr; 67(4):185-193. PubMed ID: 28261941
[TBL] [Abstract][Full Text] [Related]
5. APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis.
Crews L; Rockenstein E; Masliah E
Brain Struct Funct; 2010 Mar; 214(2-3):111-26. PubMed ID: 20091183
[TBL] [Abstract][Full Text] [Related]
6. Molecular and cellular mechanisms for Alzheimer's disease: understanding APP metabolism.
Zhang YW; Xu H
Curr Mol Med; 2007 Nov; 7(7):687-96. PubMed ID: 18045146
[TBL] [Abstract][Full Text] [Related]
7. Early intraneuronal amyloid triggers neuron-derived inflammatory signaling in APP transgenic rats and human brain.
Welikovitch LA; Do Carmo S; Maglóczky Z; Malcolm JC; Lőke J; Klein WL; Freund T; Cuello AC
Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6844-6854. PubMed ID: 32144141
[TBL] [Abstract][Full Text] [Related]
8. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
Tomiyama T
Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
[TBL] [Abstract][Full Text] [Related]
9. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.
Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I
J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161
[TBL] [Abstract][Full Text] [Related]
10. Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease.
Sambamurti K; Greig NH; Lahiri DK
Neuromolecular Med; 2002; 1(1):1-31. PubMed ID: 12025813
[TBL] [Abstract][Full Text] [Related]
11. Effect of Aβ Oligomers on Neuronal APP Triggers a Vicious Cycle Leading to the Propagation of Synaptic Plasticity Alterations to Healthy Neurons.
Rolland M; Powell R; Jacquier-Sarlin M; Boisseau S; Reynaud-Dulaurier R; Martinez-Hernandez J; André L; Borel E; Buisson A; Lanté F
J Neurosci; 2020 Jul; 40(27):5161-5176. PubMed ID: 32444385
[TBL] [Abstract][Full Text] [Related]
12. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
Bloom GS
JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of action of amyloid-beta and its precursor protein in neuronal cell death.
Leong YQ; Ng KY; Chye SM; Ling APK; Koh RY
Metab Brain Dis; 2020 Jan; 35(1):11-30. PubMed ID: 31811496
[TBL] [Abstract][Full Text] [Related]
14. Evidence of intraneuronal Aβ accumulation preceding tau pathology in the entorhinal cortex.
Welikovitch LA; Do Carmo S; Maglóczky Z; Szocsics P; Lőke J; Freund T; Cuello AC
Acta Neuropathol; 2018 Dec; 136(6):901-917. PubMed ID: 30362029
[TBL] [Abstract][Full Text] [Related]
15. Role of APP and Aβ in synaptic physiology.
Wang Z; Yang L; Zheng H
Curr Alzheimer Res; 2012 Feb; 9(2):217-26. PubMed ID: 21605029
[TBL] [Abstract][Full Text] [Related]
16. Intraneuronal APP, not free Aβ peptides in 3xTg-AD mice: implications for tau versus Aβ-mediated Alzheimer neurodegeneration.
Winton MJ; Lee EB; Sun E; Wong MM; Leight S; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2011 May; 31(21):7691-9. PubMed ID: 21613482
[TBL] [Abstract][Full Text] [Related]
17. [The beta-amyloid cascade hypothesis: a sequence of events leading to neurodegeneration in Alzheimer's disease].
Kowalska A
Neurol Neurochir Pol; 2004; 38(5):405-11. PubMed ID: 15565529
[TBL] [Abstract][Full Text] [Related]
18. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.
Pinheiro L; Faustino C
Curr Alzheimer Res; 2019; 16(5):418-452. PubMed ID: 30907320
[TBL] [Abstract][Full Text] [Related]
20. Altered calcium signaling and neuronal injury: stroke and Alzheimer's disease as examples.
Mattson MP; Rydel RE; Lieberburg I; Smith-Swintosky VL
Ann N Y Acad Sci; 1993 May; 679():1-21. PubMed ID: 8512177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
